Patents
Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
01/2006
01/11/2006EP1056732B1 4-aminothiazole derivatives, their preparation and their use as inhibitors of cyclin-dependent kinases
01/11/2006CN1720236A 4-substituted benzimidazoles and their use as inhibitors of gastric secretion
01/11/2006CN1720043A Non-nucleoside reverse transcriptase inhibitors
01/11/2006CN1718577A Medicinal composition containing alkyl acyl ramosqiong and its application
01/11/2006CN1235900C Thioether substituted imidazoquinolines
01/11/2006CN1235583C Benzimidazole derivatives as therapeutic agents
01/10/2006US6984654 Cancer treatments and pharmaceutical compositions therefor
01/10/2006US6984642 for treating cardiovascular disorders, for example for the acute and chronic treatment of ischaemic disorders
01/10/2006US6984462 Organic electroluminescent devices using double-spiro organic compounds
01/05/2006WO2005100352A8 Selected cgrp-antagonists, their preparation processes and their use as medicaments
01/05/2006US20060004066 Method for treating ADAMTS-5-associated disease
01/05/2006US20060004062 Compounds for inhibiting insulin secretion and methods related thereto
01/05/2006US20060004048 Novel biaromatic compounds which activate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof
01/05/2006DE102004027821A1 Benzimidazole, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel Benzimidazoles, process for their preparation and their use as medicaments
01/05/2006CA2567851A1 Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity
01/04/2006EP1611108A1 Method for the production of telmisartan
01/04/2006EP1611088A2 Hydroxamates as therapeutic agents
01/04/2006EP1363873A4 Peptide deformylase inhibitors
01/04/2006CN1715278A Process for preparing candesartan cilexetil C-form crystal
01/04/2006CN1234695C N-alkoxyalkyl-substituted benzimidazoles and use thereof as active agent against parasitic protozoans
01/03/2006US6982275 Oxidizing a benzylthio- or pyridylmethylthio-substituted indole or benzimidazole derivative
01/03/2006US6982264 Enzyme inhibitors of beta-secretase-mediated cleavage of amyloid precuror proteins; congnition activators; Down's syndrome; Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-type; Parkinson's disease; hemostatic agents
12/2005
12/29/2005WO2005123050A2 Five-membered heterocycles useful as serine protease inhibitors
12/29/2005WO2005122699A2 An improved process for the preparation of n-substituted hetero cyclic derivatives
12/29/2005US20050288349 Cancer treatments and pharmaceutical compositions therefor
12/29/2005US20050288348 Compounds and methods for use thereof in the treatment of cancer
12/29/2005CA2570472A1 Five-membered heterocycles useful as serine protease inhibitors
12/28/2005EP1608628A2 Histone deacetylase inhibitors
12/28/2005EP1608352A1 Polyamine compounds for treating chemokine receptor mediated diseases
12/28/2005EP1485057B1 Derivatives of azaspiro compounds for the treatment of pain
12/28/2005EP1399416A4 Peptide deformylase inhibitors
12/28/2005EP1303641B1 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching
12/28/2005EP1031563B1 Sulfonyl derivatives
12/28/2005CN1714060A Method for deuteration or tritiation of heterocyclic ring
12/27/2005CA2189271C Novel erythromycin derivatives, method for their preparation and their use as drugs
12/22/2005WO2005121103A1 Benzimidazoles, method for producing them and the use thereof as drugs
12/22/2005WO2005121102A2 Factor viia inhibitor
12/22/2005WO2005121100A1 Melanocortin-4 receptor binding compounds and methods of use thereof
12/22/2005WO2005066151A3 Histone deacetylase inhibitors
12/22/2005US20050282908 Substituted aminopropoxyaryl derivatives useful as agonists for LXR
12/22/2005US20050282881 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/22/2005US20050282805 Five-membered heterocycles useful as serine protease inhibitors
12/22/2005US20050282787 Synthesis of tetracyclines and analogues thereof
12/22/2005CA2569170A1 Factor viia inhibitor
12/22/2005CA2565698A1 Benzimidazoles, method for producing them and the use thereof as drugs
12/22/2005CA2529445A1 Melanocortin-4 receptor binding compounds and methods of use thereof
12/21/2005EP1607385A1 Intermediates for the synthesis of benzimidazole compounds and process for the preparation thereof
12/21/2005EP1606264A1 Monocyclic anilide spirohydantoin cgrp receptor antagonists
12/21/2005EP1605936A1 Aryl spirohydantoin cgrp receptor antagonists
12/21/2005CN1232518C Bi-heterocyclic compounds with antitumour and chemosensitising activity
12/20/2005US6977267 Spiro-hydantoin compounds useful as anti-inflammatory agents
12/20/2005CA2338206C High affinity ligands for nociceptin receptor orl-1
12/15/2005WO2005118556A1 Propane-1,3-dione derivative or its salt
12/15/2005WO2005118555A1 Dipeptidyl peptidase inhibitors
12/15/2005WO2005118554A2 Factor viia inhibitor
12/15/2005US20050277686 Benzimidazole compounds for regulating IgE
12/15/2005DE10210195B4 Verwendung von 1,3-Diazaspiro-[4,5]decan-2,4-dithion zur Behandlung von Schmerz Using 1,3-diazaspiro [4,5] decane-2,4-dithione for treating pain
12/15/2005CA2569163A1 Factor viia inhibitor
12/14/2005EP1604663A1 Zolpidem Hemitartrate Form H Solvate
12/14/2005EP1603881A2 Substituted thiophenes with antibacterial activity
12/14/2005EP1326845B1 N-alkoxyalkyl-substituted benzimidazoles and the use thereof as an agent against parasitic protozoans
12/14/2005EP1043976B1 Oral pharmaceutical extended release dosage form
12/14/2005CN1231467C High affinity ligands for nociceptin receptor ORL-1
12/13/2005US6974876 Method for preparing intermediates useful in synthesis of retroviral protease inhibitors
12/13/2005US6974815 effective as antagonists of Leukointegrins and/or ICAMs
12/13/2005US6974808 CRF receptor antagonists and methods relating thereto
12/13/2005US6974801 Anticancer agents; Alzheimer's diisease; Parkinson's disease; multiple sclerosis; antiinflammatory agents
12/08/2005WO2005075436A3 Novel inhibitors of glutaminyl cyclase
12/08/2005US20050272936 Imidazolium cxcr3 inhibitors
12/08/2005US20050272931 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272792 Benzimidazoles, process for their preparation and use thereof as medicament
12/08/2005US20050272765 Dipeptidyl peptidase inhibitors
12/08/2005US20050272699 1- and 2-substituted with carbo- or heterocyclic groups, e.g., 3-[4-(5-Difluoromethoxy-3-trifluoromethyl-pyrazol-1-yl)-phenyl]-2-(2-fluoro-phenyl)-acrylonitrile; inhibit the production of IL-2.
12/08/2005US20050272036 Ketones
12/07/2005EP1602648A1 Nitrogen-containing heterocycle derivative and organic electroluminescent element using the same
12/07/2005EP1601460A1 Method for producing bisphenol catalysts and bisphenols
12/07/2005EP1171442B1 Xanthine derivatives and analogs as cell signalling inhibitors
12/07/2005EP1077928B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005EP1077927B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005EP0957917B1 Vitronectin receptor antagonists
12/07/2005CN1230426C Process for the preparation of phenylene-bis-benzimidazole-tetrasulfonic acid disodium salt
12/07/2005CN1230425C Optical active compound used as intermediate in preparing optical activity 2-imidazoline-5-thionone derivatives
12/06/2005US6972293 Diagnosis and treatment of anxiety, Down Syndrome, sleep, cognitive and seizure disorders, depression, overdose with benzodiazepine drugs, and enhancement of memory and alertness; gamma-aminobutyric acid (gaba)
12/06/2005US6972281 Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof
12/06/2005CA2096528C Retroviral protease inhibitors
12/01/2005WO2005113542A2 N-cyclic sulfonamido inhibitors of gamma secretase
12/01/2005WO2005113489A1 Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies
12/01/2005WO2005112945A2 Synthesis of tetracyclines and analogues thereof
12/01/2005WO2005112640A2 Compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
12/01/2005WO2005082862A3 Benzimidazolyl derivatives as kinase inhibitors
12/01/2005WO2005060963A8 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity
12/01/2005WO2005060456A3 Method for treating adamts-5-associate disease
12/01/2005US20050267147 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
12/01/2005US20050267110 Propane-1, 3-dione derivative
12/01/2005CA2567343A1 N-cyclic sulfonamido inhibitors of gamma secretase
12/01/2005CA2566090A1 Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies
11/2005
11/30/2005EP1599167A2 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
11/30/2005EP1511385B1 Insecticidal amides with nitrogen-containing benzo-fused bicyclic ring systems
11/30/2005CN1229362C Bicyclic guanidine derivatives and therapeutic uses thereof
11/30/2005CN1229352C Improved operational amplifier output unit
1 ... 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 ... 154